BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 20, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

March 3, 2010

View Archived Issues

Dual IL-4/IL-13 receptor antagonist AER-003 reduces AHR in primates

Read More

Phase III data support use of mannitol test to identify EIB and asthma in children

Read More

Maraviroc analogue UK-484900 inhibits AHR in mice

Read More

Concert Pharmaceuticals discloses deuterated dual SV2A/Na channel blockers

Read More

Phase III data support icatibant safety and efficacy in acute HAE

Read More

Clinical data support combination of oxymetazoline and mometasone furoate for nasal congestion

Read More

Rigel identifies AXL kinase inhibitors for cancer therapy

Read More

BioDelivery Sciences presents update on BEMA Buprenorphine

Read More

Memory and Roche discover new PDE4 inhibitors

Read More

Neuraxon identifies nNOS inhibitors as analgesics

Read More

Bayer Schering claims new polo-like kinase 1 inhibitors

Read More

Antares completes enrollment in phase III Anturol trial in overactive bladder

Read More

EMA accepts voclosporin for regulatory review

Read More

Inovio to begin clinical trial of H5N1 flu DNA vaccine in Korea

Read More

InterMune submits MAA for pirfenidone for treatment of idiopathic pulmonary fibrosis

Read More

Synta resumes clinical development of elesclomol

Read More

Astellas commences tender offer to acquire OSI Pharmaceuticals

Read More

Shionogi and QuatRx to market and develop ospemifene

Read More

FDA reschedules meeting on ChemGenex's application for Omapro in CML

Read More

Renovo and Shire revise licensing deal for Juvista

Read More

FDA recommends approval of Bristol-Myers Squibb's belatacept

Read More

Celsion to begin phase II trial of ThermoDox and RFA for colorectal liver metastases

Read More

Orphan drug designation for Lithera's LIPO-102

Read More

Lundbeck inlicenses marketing rights to Azilect in Asian countries

Read More

Abbott and Enanta advance their hepatitis C collaboration

Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing